Chantal M den Bakker1, Justin K Smit2,3, Anna M E Bruynzeel4, Nicole C T van Grieken5, Freek Daams1, Sarah Derks6, Miguel A Cuesta1, John T M Plukker3, Donald L van der Peet1. 1. Department of Surgery, VU University medical center, Amsterdam, The Netherlands. 2. Department of Surgery, Ziekenhuisgroep Twente, Almelo, The Netherlands. 3. Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands. 4. Department of Radiotherapy, VU University medical center, Amsterdam, The Netherlands. 5. Department of Pathology, VU University medical center, Amsterdam, The Netherlands. 6. Department of Medical Oncology, VU University medical center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Patients with pathologic limited or no response (pNR) to neoadjuvant chemoradiation (nCRT) are subjected to curative intended esophagectomy with subsequent perioperative morbidity and mortality, but potentially only harm from nCRT. The primary aim of this study was to compare the overall survival (OS) of patients with pNR and patients who underwent primary esophagectomy to evaluate potentially benefits of nCRT in these patients. The secondary aim was to identify predictive clinicopathologic factors for pNR and pathologic complete response (pCR) to nCRT with the goal to preselect these patients before the start of treatment. METHODS: From the period 2005 to 2016, 206 esophageal cancer (EC) patients treated with Carboplatin/Paclitaxel and radiotherapy with complementary esophagectomy were included in this cohort. OS of patients with pNR was compared with a historical cohort of primary surgically treated patients (n=218) after a propensity score matching resulting in a group of 68 patients with pNR after nCRT versus a group of 68 primary esophagectomy patients. RESULTS: The OS in the pNR group and the primary esophagectomy group was comparable (P=0.986). No predictive factors were found in this cohort for pNR. Female gender (OR 2.5, 95% CI 1.2-5.3) and squamous cell carcinoma (SCC) (OR 2.6, 95% CI 1.3-5.3) were identified as independent predictive factors for pCR. CONCLUSIONS: Patients with a pNR do not benefit from nCRT followed by resection. These patients had a similar OS as those who had a primary esophagectomy alone. Although this indicates that nCRT does not negatively impact the OS of patients with pNR, patients still have an increased morbidity because of nCRT. Hence, it is important to identify factors that predict pNR. The ability to predict pNR (and pCR) will enable tailored and personalized care preventing unnecessary nCRT with increased morbidity.
BACKGROUND:Patients with pathologic limited or no response (pNR) to neoadjuvant chemoradiation (nCRT) are subjected to curative intended esophagectomy with subsequent perioperative morbidity and mortality, but potentially only harm from nCRT. The primary aim of this study was to compare the overall survival (OS) of patients with pNR and patients who underwent primary esophagectomy to evaluate potentially benefits of nCRT in these patients. The secondary aim was to identify predictive clinicopathologic factors for pNR and pathologic complete response (pCR) to nCRT with the goal to preselect these patients before the start of treatment. METHODS: From the period 2005 to 2016, 206 esophageal cancer (EC) patients treated with Carboplatin/Paclitaxel and radiotherapy with complementary esophagectomy were included in this cohort. OS of patients with pNR was compared with a historical cohort of primary surgically treated patients (n=218) after a propensity score matching resulting in a group of 68 patients with pNR after nCRT versus a group of 68 primary esophagectomy patients. RESULTS: The OS in the pNR group and the primary esophagectomy group was comparable (P=0.986). No predictive factors were found in this cohort for pNR. Female gender (OR 2.5, 95% CI 1.2-5.3) and squamous cell carcinoma (SCC) (OR 2.6, 95% CI 1.3-5.3) were identified as independent predictive factors for pCR. CONCLUSIONS:Patients with a pNR do not benefit from nCRT followed by resection. These patients had a similar OS as those who had a primary esophagectomy alone. Although this indicates that nCRT does not negatively impact the OS of patients with pNR, patients still have an increased morbidity because of nCRT. Hence, it is important to identify factors that predict pNR. The ability to predict pNR (and pCR) will enable tailored and personalized care preventing unnecessary nCRT with increased morbidity.
Authors: George W Dittrick; Jill M Weber; Ravi Shridhar; Sarah Hoffe; Marcovalerio Melis; Khaldoun Almhanna; James Barthel; James McLoughlin; Richard C Karl; Kenneth L Meredith Journal: Ann Surg Oncol Date: 2011-11-02 Impact factor: 5.344
Authors: Kenneth A Kesler; Paul R Helft; Elizabeth A Werner; Neel P Jain; Jo Ann Brooks; John M DeWitt; Julia K Leblanc; Naomi S Fineberg; Lawrence H Einhorn; John W Brown Journal: Ann Thorac Surg Date: 2005-04 Impact factor: 4.330
Authors: Pooja R Rohatgi; Stephen G Swisher; Arlene M Correa; Tsung T Wu; Zhongxing Liao; Ritsuko Komaki; Garrett L Walsh; Ara A Vaporciyan; David C Rice; Robert S Bresalier; Jack A Roth; Jaffer A Ajani Journal: Cancer Date: 2006-02-01 Impact factor: 6.860
Authors: Pooja Rohatgi; Stephen G Swisher; Arlene M Correa; Tsung-T Wu; Zhongxing Liao; Ritsuko Komaki; Garrett L Walsh; Ara A Vaporciyan; David C Rice; Jack A Roth; Jaffer A Ajani Journal: Cancer Date: 2005-12-01 Impact factor: 6.860
Authors: Nabil P Rizk; Ennapadam Venkatraman; Manjit S Bains; Bernard Park; Raja Flores; Laura Tang; David H Ilson; Bruce D Minsky; Valerie W Rusch Journal: J Clin Oncol Date: 2007-02-10 Impact factor: 44.544
Authors: Robert Eil; Brian S Diggs; Samuel J Wang; James P Dolan; John G Hunter; Charles R Thomas Journal: Cancer Date: 2013-11-05 Impact factor: 6.860
Authors: David P Kelsen; Katryn A Winter; Leonard L Gunderson; Joanne Mortimer; Norman C Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; Jack A Roth; Christopher G Willett Journal: J Clin Oncol Date: 2007-08-20 Impact factor: 44.544
Authors: Bo Jan Noordman; Joel Shapiro; Manon Cw Spaander; Kausilia K Krishnadath; Hanneke Wm van Laarhoven; Mark I van Berge Henegouwen; Grard Ap Nieuwenhuijzen; Richard van Hillegersberg; Meindert N Sosef; Ewout W Steyerberg; Bas Pl Wijnhoven; J Jan B van Lanschot Journal: JMIR Res Protoc Date: 2015-06-29
Authors: Guillaume S Chevrollier; Danica N Giugliano; Francesco Palazzo; Scott W Keith; Ernest L Rosato; Nathaniel R Evans Iii; Adam C Berger Journal: J Gastrointest Surg Date: 2019-02-26 Impact factor: 3.452
Authors: Chien-Hung Chiu; Peng Zhang; Andrew C Chang; Brian A Derstine; Brian E Ross; Binu Enchakalody; Nidhi V Shah; Stewart C Wang; Yin-Kai Chao; Jules Lin Journal: Ann Thorac Surg Date: 2019-09-21 Impact factor: 4.330
Authors: Leonie K de Klerk; Ruben S A Goedegebuure; Adam J Bass; Sarah Derks; Nicole C T van Grieken; Johanna W van Sandick; Annemieke Cats; Jurrien Stiekema; Rosa T van der Kaaij; Arantza Farina Sarasqueta; Manon van Engeland; Maarten A J M Jacobs; Roy L J van Wanrooij; Donald L van der Peet; Aaron R Thorner; Henk M W Verheul; Victor L J L Thijssen Journal: Mol Oncol Date: 2021-02-23 Impact factor: 6.603
Authors: G W van Pelt; J A Krol; I M Lips; F P Peters; D van Klaveren; J J Boonstra; W O de Steur; R A E M Tollenaar; A Farina Sarasqueta; W E Mesker; M Slingerland Journal: Clin Transl Radiat Oncol Date: 2019-11-27